UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000032801 |
|---|---|
| Receipt number | R000037236 |
| Scientific Title | Phase I study of TAS-116 in combination with Nivolumab in patients with progressive or metastatic solid cancer |
| Date of disclosure of the study information | 2018/06/01 |
| Last modified on | 2021/02/22 13:58:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/05/31 10:48:07 | ||
| 2 | Update | 2018/08/02 13:24:11 | Recruitment status |
|
| 3 | Update | 2019/12/02 09:44:58 | Date of IRB Last follow-up date |
|
| 4 | Update | 2019/12/02 10:06:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Address1 Tel1 Organization Organization Address Address Tel |
|
| 5 | Update | 2020/01/16 11:55:14 | Recruitment status |
|
| 6 | Update | 2021/02/22 13:58:42 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
